<DOC>
	<DOCNO>NCT02749110</DOCNO>
	<brief_summary>This study evaluate benefit woman age 30 65 year , participate French opportunistic cervical cancer screen program , organize screen proposition family physician pap-test ( usual care ) versus self-collected vaginal sample ( HPV-test ) . 24 family physician participate randomize usual care arm ( 12 ) self-sampling arm ( 12 ) . Our hypothesis organize screen woman involve family physician major participation , self-sampling option amplify increase .</brief_summary>
	<brief_title>Participation Screening Cervical Cancer : Interest Self-sampling Device Provided General Practitioner</brief_title>
	<detailed_description>In France screen cervical cancer ( CC ) usually base opportunistic screen program . French guidance recommend perform smear every 3 year age 25 65 year , 2 initial normal yearly smear . Pap-tests carry medical doctor midwife . The coverage rate estimate 56.6 % 83.0 % . In deprived population , 55 % woman unscreened risk develop CC majored . The gynecologic examination consultation gynecologist appear main barrier pap-test . Almost unscreened woman visit family physician least yearly relative , many family physician perform pap-tests . Our hypothesis woman screen invited family physician ( carry pap-test refers woman gynecologist midwife ) , screen rate major family physician delivers female patient , willing undergo pap-smear , vaginal self-sampling device . To demonstrate , conduct open label 1:1 cluster randomize control trial . As gender physician ability carry pap-tests associated rate list screen female patient , randomization stratify two variable . The 24 participate physician ( 12 study arm ) enroll 2000 unscreened female patient . The study population social security insure unscreened list woman age 30 65 year participate physician . As specificity HPV-test screen CC insufficient age 30 , woman 25 29 year age part study . All woman ( unless exclusion criterion appear medical record ) receive family physician invitation letter make appointment encounter dedicate CC screen . Women accept enrol study sign consent form invite fill questionnaire socio-economic profile belief attitudes prevention , cancer screen general screen CC particular . Participation screen process necessary inclusion . Women control arm solely propose undergo pap-test perform family physician gynecologist midwife . Women intervention arm alternatively propose proceed home perform vaginal self-collection sample send post centralize lab HPV testing . HPV test conduct virology lab University Hospital Lille . All screen negative woman arm study consider successful outcome finish study . HPV screen positive woman self-collection arm propose triage pap-test colposcopy . Further 18 month follow-up matching French guideline .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Carcinoma Situ</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Cervical Intraepithelial Neoplasia</mesh_term>
	<criteria>To woman Aged 30 65 year ( 30 65 year include ) Without reimbursement paptest health insurance 3 year , despite reminder mail health insurance previous year ( list set health insurance ) . Able understand sign voluntarily consent participate Warranted health insurance Able understand answer question study questionnaire alone help selfchosen third party . No vaginal intercourse ever Paptest quote another budget ( hospital , mother child protection… ) conduct less 3 year ago Known cervical lesion know HPV status History hysterectomy History conisation History laser treatment cervix History cervical cancer Other medical reason delay cervical cancer screen Abroad one year Moving another region ( do expect ) Pregnant breastfeed Screening relevant practitioner 's perspective ( Emergency situation , comorbidity… )</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Mass screening</keyword>
	<keyword>Family medicine</keyword>
	<keyword>Human Papillomavirus DNA test</keyword>
	<keyword>Papanicolaou test</keyword>
	<keyword>Early detection cancer/methods*</keyword>
	<keyword>Specimen Handling/methods*</keyword>
	<keyword>Patient compliance</keyword>
	<keyword>Adult</keyword>
	<keyword>Female</keyword>
	<keyword>Humans</keyword>
	<keyword>Randomized control trial</keyword>
</DOC>